The Society of Toxicology has established a special category for organizations who wish to contribute to the success of SOT toward “creating a safer and healthier world by advancing the science of toxicology.” SOT Affiliates have no voting rights or other special privileges.
The President of the Society, with the approval of the Council, may on an annual basis invite any firm, association, corporation, institution, or subdivision thereof, to become an SOT Affiliate in support of the Society.
Read more about the benefits of having an SOT Affiliate status or contact SOT Headquarters.
American Petroleum Institute
AstraZeneca Pharmaceuticals LP
Boehringer Ingelheim Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Chevron Energy Technology Company
Dow Chemical Company
Dow Corning Corporation
Eli Lilly & Company
ExxonMobil Biomedical Sciences, Inc.
South San Francisco,
Gilead Sciences, Inc.
King of Prussia,
Honeywell International, Inc.
Huntingdon Life Sciences/Harlan
Janssen Pharmaceutical R&D LLC
Millennium: The Takeda Oncology Company
Procter & Gamble Company
Regeneron Pharmaceuticals, Inc.
RTC Research Toxicology Centre S.p.A.
SNBL USA, Ltd.
Syngenta Crop Protection, Inc.
The DuPont Haskell Global Centers for Health and Environmental Sciences
The Hamner Institutes for Health Sciences
Research Triangle Park,
Toxicology Excellence for Risk Assessment (TERA)
Western Slope Laboratory LLC
WIL Research Laboratories, LLC
XRpro Sciences, Inc.
SOT reviews the character of supporters and approves receiving funding from supporters. SOT reserves the right to refuse acceptance of funds from any organization whose goals, objectives, or past actions are deemed counterproductive to those of the Society. SOT does not accept contributions from tobacco companies, nor does it permit tobacco companies to be SOT Affiliates.